Today, the United States Consumer Product Safety Commission (CPSC) issued an official recall for the Galaxy Note 7, the Korean electronics manufacturer Samsung’s flagship large-screen smartphone, which is widely viewed as the arch-rival of Apple’s iPhone. The recall was issued for all Note 7 smartphones sold before September 15, 2016 and was based on 92 reports received by Samsung (and later reported to the CPSC)¬†of the devices’ batteries overheating during charging, causing some of the phones to burst into flames and causing serious personal injuries. ¬†This week, a man who suffered third degree burns when his Galaxy Note 7 exploded, filed a products liability lawsuit against the Korean smartphone manufacturer in New Jersey state court.
The lithium-ion batteries used in the Galaxy Note 7. and several other consumer electronics, have been the subject of several reports in recent years of exploding hoverboards , overheating laptops, and causing electrical disturbances on airplanes. ¬†However, due to the widespread use of smartphones, the explosion risk posed by the Note 7 could cause a serious dent into the brand image for Samsung, who is the world’s largest smartphone manufacturer and is considered to be Apple’s chief competitor in the high-end smartphone ¬†market. Given the ubiquity of smartphones, it is very likely that more personal injury lawsuits will follow the one that was filed in New Jersey this week, causing even more damage to Samsung’s reputation, and consequently to¬†its bottom line.
The CPSC’s recall allows the U.S. government to take several steps to address the risk posed by the Note 7 smartphones, including making it illegal to continue selling the devices or use them on airplanes. Indeed, even before the recall was announced today, several airlines have banned passengers from using or charging their Note 7’s on flights due to the risk of explosion. A similar ban was instituted by airlines for hoverboards containing lithium-ion batteries during the busy holiday travel season last year, which are prone to exploding even when not in use.
Samsung has been criticized by consumer advocates and U.S. regulators for its initial response to to the safety crisis. In late August, Samsung announced that it would delay shipments of the Note 7 following reports in the Korean media of exploding handsets. Earlier this month, the company announced a voluntary replacement program, but did not inform U.S. regulators about it prior to making the program public-a potential violation of U.S. law governing recalls of consumer products. ¬†Additionally, Samsung has been criticized for downplaying the risk posed by the Note 7, most notably for telling its customers in South Korea that the problem could be fixed by simply downloading a software patch onto their phones that would limit the charge on the device’s batteries, implying that the phones were safe to use so long as they were not fully charged. You can read more about the Note 7 recall here: ¬†https://www.washingtonpost.com/news/the-switch/wp/2016/09/15/consumer-product-safety-commission-issues-an-official-recall-for-the-galaxy-note-7/
This isn’t the first time that Samsung has faced controversy over reports of its consumer products causing personal injuries and property damages. There have been several reports worldwide¬†over the last few years that Samsung’s popular top loading washing machines have a tendency to explode during operation due to a design defect that caused the internal drums in the machines to come loose and become disengaged when the steel suspension mounts securing them failed. Consumers across the globe have also reported that Samsung washers have been prone to catch fire spontaneously and leak water, causing extensive property damage. An exploding Samsung washer caused injury to a California woman, who filed suit against the company in 2014.¬†
The trial attorneys at the Law Offices of Brian D. Witzer have extensive experience in litigating product liability claims involving defective consumer appliances, automobiles, heavy machinery, medical devices, and dangerous drugs, and have achieved record setting results for our clients. If you or a loved one have been injured by an exploding Galaxy Note 7 smartphone, or any other defective consumer appliance, contact the lawyers at the Law Offices of Brian D. Witzer for a free consultation regarding your legal rights.
On Tuesday May 10, 2016, the U.S. Food and Drug Administration (FDA) issued a warning to healthcare professionals and patients regarding the mental health drug olanzapine, which is used in popular anti-psychotic medications such as Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax. The FDA warning concerns the ability of olanzapine to cause a serious and potentially fatal drug reaction that begins with a serious skin reaction and then progresses to affect other parts of the body, including major organ systems like the heart, kidney, and liver.
The reaction, known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), often begins with skin rash and swollen lymph glands, or swelling in the face. The FDA advised patients on olanzapine to immediately seek medication attention if they develop these¬†symptoms. The agency also advised healthcare professionals to explain the signs and symptoms of severe skin reactions to their patients and instruct them when to seek medical care when prescribing drugs containing olanzapine. ¬†Olanzapine is an anti-psychotic medication used to treat schizophrenia and bipolar disorder.
DRESS can start as a rash that spreads to the entire body, and can also include fever, swollen lymph nodes, and swollen face. The reaction produces a higher-than-normal number of white blood cells called eosinophils, which are used to fight infections, leading to inflammation and swelling. ¬†DRESS can ultimately cause serious injury to major organ systems, including the liver, kidney, lungs, heart or pancreas, and can be fatal.
The FDA issued the warning after analyzing reports in its drug safety database which tracks adverse reactions associated with various medications that are reported to the agency. The FDA found 23 cases of DRESS reported with the use of olanzapine worldwide since the drug was first approved in 1996. However, since many drug induced adverse reactions are not reported to the agency, the FDA believes that the actual number of cases of olanzapine induced DRESS is¬†likely far higher. ¬†You can read the entire FDA Safety Alert for olanzapine here:¬†http://www.fda.gov/Drugs/DrugSafety/ucm499441.htm.
The information that the FDA based its decision to warn about DRESS on all medications containing olanzapine was equally available to manufacturers of these drugs. Federal regulations require drug manufacturers to monitor the safety of their products and implement additional warnings regarding adverse reactions associated with their drugs. While the FDA is tasked with ensuring all prescription and non-prescription drugs prescribed in the U.S. are safe and effective, it lacks the resources to actively monitor the more than 5,000 drugs in the U.S. marketplace. ¬†This is why federal law requires drug makers to routinely submit safety information about their products to the FDA once they are approved for sale. However, many drug companies often choose to wait¬†for the FDA to require additional warnings of adverse reactions for their products so as not to deter physicians from prescribing them to their patients, thereby¬†putting profit over the safety of patients who use their drugs.
The Law Offices of Brian D. Witzer has extensive experience representing patients who have been injured by defective drugs and medical devices, and have routinely gone up¬†against some of the largest pharmaceutical and medical device manufacturers in the world. Our firm has unique, specialized experience in representing consumers who have developed DRESS from a variety of medications. The firm was the first in the U.S. to successfully sue the manufacturer of a popular prescription acne medication for failing to timely warn that its product could cause DRESS in patients. Our clients’ teenage daughter was prescribed the medication for moderate acne, which at the time did not include warnings of DRESS. Their daughter eventually developed DRESS and after several months in the hospital, tragically succumbed to the reaction after it caused major damage to her heart. ¬†After this incident, the FDA required warnings of DRESS on the drug’s labeling. The attorneys at our firm were able to prove that the information that led to the FDA mandated warnings had been available to the drug’s manufacturer for several years before our clients’ daughter was prescribed the medication.
If you or a loved one has experienced DRESS as a result of taking mental health medications such as Zyprexa or¬†Symbyax, contact the attorneys at the Law Offices of Brian D. Witzer for a free consultation to discuss your legal rights.
According to a new report recently discovered in a FDA safety database which tracks injuries from medical devices, 3 patients died last year at Huntington Hospital in Pasadena, CA from a superbug infection caused by tainted medical scopes. ¬†Huntington Hospital officials confirmed in August of last year that three patients were sickened by the scopes and later alerted the manufacturer of the patient deaths, according to the manufacturer’s report to the FDA. ¬†You can read more about the recent patient deaths at Huntington Hospital here: ¬†http://www.latimes.com/business/la-fi-olympus-scope-pasadena-20160504-snap-story.html.
The manufacturer, Olympus Corporation, recalled a similar medical scope in January due to design flaws that prevented hospitals and other healthcare providers from cleaning the re-usable medical device between use in different patients. ¬†That model has been linked to numerous superbug outbreaks at U.S. hospitals, including UCLA Ronald Reagan and Cedars-Sinai, which have resulted in several patient deaths over the last two years.The scopes, which are long snake-like tubes, are used to diagnose diseases in a patient’s bile and pancreatic¬†ducts by inserting their long snake-like tubes in the patient’s throat and upper gastrointestinal tract.
The Law Offices of Brian D. Witzer currently represents patients who were infected by the Olympus scopes at UCLA Ronald Reagan Hospital and is currently evaluating cases arising from superbug outbreaks caused by contaminated Olympus duoendoscopes at U.S. hospitals, including the recent outbreak at Huntington¬†Hospital. If you or a loved one was infected with a superbug from a contaminated scope, contact the attorneys at the Law Offices of Brian D. Witzer today for a free consultation to determine your legal rights.